EPS Bio Technology Corp. (TPEX:4183)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.25
+0.15 (0.93%)
Mar 6, 2026, 11:46 AM CST
Market Cap383.18M -30.3%
Revenue (ttm)497.19M +2.5%
Net Income-14.24M
EPS-0.60
Shares Out23.80M
PE Ration/a
Forward PEn/a
Dividend0.67 (4.17%)
Ex-Dividend DateAug 28, 2025
Volume6,048
Average Volume9,179
Open16.10
Previous Close16.10
Day's Range16.10 - 16.25
52-Week Range15.65 - 23.40
Beta0.19
RSI45.78
Earnings DateMar 11, 2026

About EPS Bio Technology

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan. [Read more]

Sector Healthcare
Founded 2006
Employees 109
Stock Exchange Taipei Exchange
Ticker Symbol 4183
Full Company Profile

Financial Performance

In 2024, EPS Bio Technology's revenue was 451.08 million, a decrease of -4.06% compared to the previous year's 470.17 million. Earnings were 17.31 million, a decrease of -17.54%.

Financial Statements